Patricia Louise Brazee, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Fibrosis | 4 | 2024 | 503 | 1.580 |
Why?
|
| Lung Injury | 4 | 2020 | 430 | 1.520 |
Why?
|
| Orthomyxoviridae Infections | 2 | 2024 | 254 | 1.300 |
Why?
|
| Influenza A virus | 2 | 2020 | 453 | 1.070 |
Why?
|
| Respiratory Mucosa | 1 | 2020 | 438 | 0.530 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2020 | 452 | 0.510 |
Why?
|
| Multiprotein Complexes | 1 | 2020 | 1107 | 0.430 |
Why?
|
| Health | 1 | 2016 | 397 | 0.420 |
Why?
|
| Ubiquitination | 1 | 2016 | 996 | 0.370 |
Why?
|
| Disease | 1 | 2016 | 676 | 0.350 |
Why?
|
| Ubiquitin | 3 | 2020 | 839 | 0.340 |
Why?
|
| Lung | 6 | 2023 | 10033 | 0.330 |
Why?
|
| Immunity | 2 | 2020 | 1002 | 0.230 |
Why?
|
| Paroxetine | 1 | 2024 | 180 | 0.210 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type II | 1 | 2023 | 72 | 0.210 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3223 | 0.200 |
Why?
|
| Hypercapnia | 1 | 2023 | 259 | 0.190 |
Why?
|
| Endothelium | 1 | 2024 | 767 | 0.180 |
Why?
|
| Capillary Permeability | 2 | 2022 | 768 | 0.180 |
Why?
|
| rho-Associated Kinases | 2 | 2023 | 291 | 0.170 |
Why?
|
| Interferon Regulatory Factor-1 | 1 | 2020 | 70 | 0.170 |
Why?
|
| Myosin-Light-Chain Kinase | 1 | 2018 | 102 | 0.140 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2022 | 518 | 0.130 |
Why?
|
| Animals | 11 | 2024 | 168764 | 0.120 |
Why?
|
| Dogs | 1 | 2020 | 3822 | 0.120 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2017 | 479 | 0.120 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2017 | 618 | 0.110 |
Why?
|
| Calcium-Binding Proteins | 1 | 2018 | 1077 | 0.110 |
Why?
|
| Protein Isoforms | 1 | 2018 | 1718 | 0.110 |
Why?
|
| Protein Kinase C | 1 | 2017 | 1202 | 0.100 |
Why?
|
| Alternative Splicing | 1 | 2018 | 1107 | 0.100 |
Why?
|
| Endothelial Cells | 2 | 2022 | 3584 | 0.090 |
Why?
|
| Mice | 7 | 2024 | 81819 | 0.090 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2020 | 1892 | 0.090 |
Why?
|
| Glucuronidase | 1 | 2012 | 203 | 0.090 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2016 | 1314 | 0.080 |
Why?
|
| Mice, Knockout | 3 | 2020 | 14448 | 0.080 |
Why?
|
| Bleomycin | 2 | 2022 | 491 | 0.080 |
Why?
|
| Myofibroblasts | 2 | 2023 | 229 | 0.080 |
Why?
|
| Fibroblasts | 1 | 2018 | 4159 | 0.070 |
Why?
|
| Humans | 10 | 2024 | 765968 | 0.060 |
Why?
|
| Carrier Proteins | 1 | 2017 | 4913 | 0.060 |
Why?
|
| Transcription Factors | 1 | 2023 | 12131 | 0.050 |
Why?
|
| Serum Response Factor | 1 | 2023 | 78 | 0.050 |
Why?
|
| Retrospective Studies | 2 | 2020 | 81514 | 0.050 |
Why?
|
| Signal Transduction | 1 | 2023 | 23601 | 0.040 |
Why?
|
| Sphingosine | 1 | 2022 | 306 | 0.040 |
Why?
|
| Lysophospholipids | 1 | 2022 | 335 | 0.040 |
Why?
|
| beta Catenin | 1 | 2023 | 1043 | 0.040 |
Why?
|
| Nanotechnology | 1 | 2023 | 703 | 0.030 |
Why?
|
| Mice, Inbred ICR | 1 | 2017 | 339 | 0.030 |
Why?
|
| Haploinsufficiency | 1 | 2018 | 334 | 0.030 |
Why?
|
| Epithelial Cells | 2 | 2018 | 3681 | 0.030 |
Why?
|
| COS Cells | 1 | 2017 | 1136 | 0.030 |
Why?
|
| Blood Coagulation | 1 | 2022 | 1166 | 0.030 |
Why?
|
| Fibrosis | 1 | 2023 | 2070 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 2017 | 647 | 0.030 |
Why?
|
| Pulmonary Alveoli | 1 | 2017 | 664 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2022 | 2666 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 11888 | 0.030 |
Why?
|
| Endocytosis | 1 | 2017 | 951 | 0.030 |
Why?
|
| Cell Differentiation | 2 | 2023 | 11641 | 0.030 |
Why?
|
| Opossums | 1 | 2012 | 104 | 0.020 |
Why?
|
| Apoptosis | 2 | 2018 | 9514 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2022 | 22332 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2017 | 2927 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2022 | 2535 | 0.020 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2012 | 720 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2022 | 9550 | 0.020 |
Why?
|
| RNA Interference | 1 | 2017 | 2832 | 0.020 |
Why?
|
| Rats | 2 | 2017 | 23707 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2017 | 3421 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2017 | 3634 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2023 | 10429 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2017 | 8278 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2017 | 8102 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2012 | 4165 | 0.020 |
Why?
|
| Fibroblast Growth Factors | 1 | 2012 | 871 | 0.020 |
Why?
|
| Phenotype | 1 | 2022 | 16721 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 18293 | 0.010 |
Why?
|
| Cell Line | 1 | 2012 | 15543 | 0.010 |
Why?
|
| Kidney | 1 | 2012 | 7066 | 0.010 |
Why?
|
| Mutation | 1 | 2017 | 30198 | 0.010 |
Why?
|
| Aging | 1 | 2012 | 8731 | 0.010 |
Why?
|
| Male | 1 | 2017 | 363698 | 0.000 |
Why?
|